share_log

Santen Pharmaceutical 1H Net Y14.31B Vs Net Y13.81B

Santen Pharmaceutical 1H Net Y14.31B Vs Net Y13.81B

三騰藥業1H淨值14.31億日元vs淨值13.81億日元
Dow Jones Newswires ·  2021/11/08 01:12 

    Santen Pharmaceutical Co. Ltd. (4536.TO) 
    Japan 
    1st Half Ended September 30 
GROUP                2021                 2020 
Revenue              Y128.76 bln   Y118.91 bln 
Operating Profit     Y18.81 bln     Y18.69 bln 
Pretax Profit        Y18.39 bln     Y18.35 bln 
Net Profit           Y14.31 bln     Y13.81 bln 
Per share 
  Earnings           Y35.79             Y34.58 
  Diluted Earnings   Y35.73             Y34.50 
    Results are based on IFRS accounting standards. 
三天藥業股份有限公司(4536.TO)日本截至9月30日的上半年集團2021 2020營收1287.6億日元1189.1億日元營業利潤188.1億日元186.9億日元税前利潤183.9億日元183.5億日元淨利潤143.1億日元138.1億日元每股收益35.79 Y34.58稀釋後收益35.73日元34.50日元結果是基於“國際財務報告準則”的會計準則。

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

此內容是基於來自原始源的數據和/或文本自動發佈的。如需反饋，請寫信至singaporeeders@dowjones.com。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論